Read the interview of our President Bernard Orlandini, along with Marc Essodaigui, CEO of Active Biomarkers and Alexandre Durand-Salmon, CEO of Banook Group.
They share with us their expertise on how to optimize the outcomes of clinical trials using Modeling and Simulation, Biomarkers and cardiac safety.
↓↓ Read the full article below ↓↓
